Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 7, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 4, 2020

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Beinaglutide

"1. Beinaglutide for 8 weeks,~2. Beinaglutide + glargine for 8 weeks(only the subjects whose blood glucose not reach the standard )"

DRUG

glargine

"1. Glargine for 8 weeks,~2. Glargine+Beinaglutide for 8 weeks(only the subjects whose blood glucose not reach the standard )"

Trial Locations (2)

710016

Chang'an Hospital, Xi'an

710025

Shaanxi Aerospace Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER